Regeneron said Monday it will “prioritize the privacy, security and ethical use” of the personal DNA data from about 15 million people in a $256 million deal to acquire assets of bankrupt ...

Viva Biotech, a company provides one-stop services ranging from early-stage structure-based drug R&D to commercial manufacturing to global biopharmaceutical innovators, successfully held the AIDD ...

The executive chairman of Strathcona Resources Ltd. says his company aims to join two complementary oilsands players with its unsolicited takeover bid for MEG Energy Corp., but one analyst calls ...

The Titan Biotech Limited has send a notice to the concerned shareholder and publish the notice in the newspaper to concerned shareholders whose dividend(s) are unclaimed for 7 consecutive years and ...

MEG Shareholders and Strathcona Shareholders are encouraged to review a presentation describing the benefits of the Offer, which has been posted on Strathcona's website at www.strathconaresources ...

NEW YORK — Cal­ley Means, a spe­cial White House em­ploy­ee and top ad­vi­sor to HHS Sec­re­tary Robert F. Kennedy Jr., ef­fec­tive­ly dared Roche to pull its … ...

[SINGAPORE] Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as it seeks to raise HK$1.09 billion (S$181 million) to further grow the ...

A non-GAAP financial measure which does not have a standardized meaning under the Accounting Standards; see "Specified Financial Measures" section of this press release. Assumes cash and share ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

A non-GAAP financial measure which does not have a standardized meaning under the Accounting Standards; see “Specified Financial Measures” section of this press release. Assumes cash and share ...

ensure the well-being of the dairy industry, and advance the nation’s Atmanirbhar Bharat vision,” said Krishna Ella, founder, Biovet, and executive chairman, Bharat Biotech, in a statement.